Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
暂无分享,去创建一个
C. Clavel | P. Birembaut | M. Lorenzato | P Nazeyrollas | C Clavel | M Masure | J-P Bory | I Putaud | C Mangeonjean | M Lorenzato | R Gabriel | C Quereux | P Birembaut | P. Nazeyrollas | R. Gabriel | C. Quéreux | M. Masure | J. Bory | I. Putaud | C. Mangeonjean | Philippe L. Birembaut | Bory Jp
[1] K. Beutner. Human papillomavirus infection. , 1989, Journal of the American Academy of Dermatology.
[2] C. Peyton,et al. Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies , 1998, Journal of Clinical Microbiology.
[3] C. Clavel,et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. , 1998, Journal of clinical pathology.
[4] R Reid,et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.
[5] C. Clavel,et al. Comparative analysis of human papillomavirus detection by hybrid capture assay and routine cytologic screening to detect high‐grade cervical lesions , 1998, International journal of cancer.
[6] C. Meijer,et al. PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears , 1996, International journal of cancer.
[7] A. Schneider,et al. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. , 1996, American journal of obstetrics and gynecology.
[8] H. zur Hausen. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. , 1994, Current topics in microbiology and immunology.
[9] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[10] J. T. Cox,et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. , 1995, American journal of obstetrics and gynecology.
[11] R. Hiatt,et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. , 1999, JAMA.
[12] L. Koutsky,et al. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. , 2000 .
[13] David R. Scott,et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. , 2001, The Journal of infectious diseases.
[14] S Wacholder,et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. , 2000, JAMA.
[15] J. Cuzick,et al. Human papillomavirus testing in primary cervical screening , 1995, The Lancet.
[16] R. Kaufman,et al. Is human papillomavirus testing of value in clinical practice? , 1999, American journal of obstetrics and gynecology.
[17] Julian Peto,et al. Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .
[18] C. Clavel,et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women , 1999, British Journal of Cancer.
[19] L Beardsley,et al. Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.
[20] T. Rohan,et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. , 1999, The Journal of infectious diseases.
[21] H. Adami,et al. Natural history of cervical neoplasia: consistent results obtained by an identification technique. , 1989, British Journal of Cancer.
[22] M. Plummer,et al. Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica , 2000 .
[23] T. Wright,et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. , 2000, Journal of the National Cancer Institute.
[24] J. Cuzick,et al. HPV testing in primary screening of older women , 1999, British Journal of Cancer.
[25] R. Burk,et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. , 1995, Journal of the National Cancer Institute.
[26] G. Rebello,et al. Human papillomavirus testing , 2001, BMJ : British Medical Journal.
[27] S. Vernon,et al. Comparison of Human Papillomavirus Detection and Typing by Cycle Sequencing, Line Blotting, and Hybrid Capture , 2000, Journal of Clinical Microbiology.
[28] J. Cuzick,et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions , 2000, British Journal of Cancer.
[29] P. Arveux,et al. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. , 1999 .
[30] E. Franco,et al. Human papillomavirus testing for primary screening of cervical cancer precursors. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] T. Wright,et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. , 1998, American journal of obstetrics and gynecology.
[32] J. Walboomers,et al. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia , 1993, International Journal of Gynecologic Cancer.
[33] C. Meijer,et al. The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months , 1995, International journal of cancer.
[34] Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. , 1995, American journal of obstetrics and gynecology.
[35] Jacalyn L. Papillo,et al. Evaluation of the ThinPrep Pap Test in Clinical Practice , 1998, Acta Cytologica.
[36] J. Walboomers,et al. HPV typing and testing in gynaecological pathology: has the time come? , 1998, Histopathology.
[37] J. Cuzick,et al. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. , 1994, British Journal of Cancer.
[38] Mark H Stoler,et al. Advances in Cervical Screening Technology , 2000, Modern Pathology.
[39] M. Plummer,et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.
[40] A. Lorincz. Hybrid Capture™ Method for Detection of Human Papillomavirus DNA in Clinical Specimens: A Tool for Clinical Management of Equivocal Pap Smears and for Population Screening , 1996 .
[41] M. Schiffman,et al. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. , 2001, Journal of the National Cancer Institute.
[42] S. Crawford. Screening for cervical intraepithelial neoplasia , 1994, BMJ.
[43] A. Morabia,et al. Efficacy of a liquid‐based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer , 2000 .
[44] H. Adami,et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.
[45] A. Lörincz,et al. Hybrid Capture™ Method for Detection of Human Papillomavirus DNA in Clinical Specimens: A Tool for Clinical Management of Equivocal Pap Smears and for Population Screening , 1996, The journal of obstetrics and gynaecology research.
[46] R. Ashfaq,et al. Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[47] W. Reeves,et al. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? , 1998, American journal of obstetrics and gynecology.